4.2 Article

Diagnostic value of heart-to-mediastinum ratio in 99mTc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters

Satoru Watanabe et al.

Summary: Volumetric evaluation of Tc-99m-PYP SPECT/CT may be superior to conventional parameters in assessing ATTR-CA, showing higher sensitivity and specificity. In patients with ATTR-CA, cardiac pyrophosphate volume demonstrated stronger correlations with cardiac function and structure, indicating its advantages in disease evaluation.

JOURNAL OF NUCLEAR CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review

Katrine Bay et al.

Summary: Wild-type transthyretin amyloid cardiomyopathy (ATTRwt CM) is a common disease with challenging diagnosis. Recent advances and treatment options have increased interest in ATTRwt CM. This study aims to summarize the scientific knowledge and gaps related to suspicion, diagnosis, and screening of ATTRwt CM. Analysis of 50 articles revealed common suspicion criteria such as ventricular wall thickening, carpal tunnel syndrome, and late gadolinium enhancement on CMR. Diagnostic pathways varied slightly, but most included bone scintigraphy, exclusion of other diseases, and the possibility of biopsy. Systematic screening was mentioned in some articles, suggesting specific populations for screening.

ESC HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis

Robert J. H. Miller et al.

Summary: Quantitative assessment of myocardial radiotracer activity with CPA or VOI has high diagnostic accuracy for ATTR-CM, with CPA showing higher accuracy compared to Perugini score. In patients with ATTR-CM, CPA is associated with reduced left ventricular ejection fraction and heart failure hospitalizations.

JOURNAL OF NUCLEAR CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious infiltrative disease caused by the deposition of amyloid fibrils in the heart, which can be due to genetic variants or acquired conditions. With advances in imaging techniques, non-invasive diagnosis is now possible, showing that cardiac amyloidosis is more common than previously thought. The Working Group on Myocardial and Pericardial Disease has proposed definitions and diagnostic algorithms for cardiac amyloidosis.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia et al.

Summary: Cardiac amyloidosis is a serious and progressive infiltrative disease caused by amyloid fibril deposition in the heart. Advances in imaging techniques and diagnostic algorithms have made it possible to diagnose the condition non-invasively. Monitoring and treating cardiac amyloidosis are important in bridging the gap between research advances and clinical practice.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis

Mazen Hanna et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis

Hiroaki Kitaoka et al.

CIRCULATION JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality

Brett W. Sperry et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Article Medicine, General & Internal

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Mathew S. Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Biochemistry & Molecular Biology

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Merrill D. Benson et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population

Stuart C. Ramsay et al.

EUROPEAN JOURNAL OF HYBRID IMAGING (2018)

Letter Cardiac & Cardiovascular Systems

Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?

Muhammad Haq et al.

JACC-CARDIOVASCULAR IMAGING (2017)

Article Cardiac & Cardiovascular Systems

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore et al.

CIRCULATION (2016)

Article Cardiac & Cardiovascular Systems

Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis

Nowell M. Fine et al.

AMERICAN JOURNAL OF CARDIOLOGY (2014)

Editorial Material Cardiac & Cardiovascular Systems

Nuclear Tracers for Transthyretin Cardiac Amyloidosis Time to Bone Up?

Frederick L. Ruberg et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2013)